ÀǾàǰÁ¤º¸ | ³¹¾Ë½Äº°Á¤º¸ | ¾ÈÀü¼º ¹®ÇåÁ¤º¸
PM2000 DIK 2.0 KPA MSG
 
 
Controlled studies show no risk. Adequate, well-controlled studies in pregnant women have failed to demonstrate risk to the fetus.
Á¶ÀýµÈ ¿¬±¸¿¡¼­ À§Ç輺ÀÌ ¾øÀ½À» º¸¿´´Ù.
ÀӺο¡ ´ëÇÑ ÀûÀýÇϰí Àß Á¶ÀýµÈ ¿¬±¸¿¡¼­, žƿ¡ ´ëÇÑ À§Ç輺ÀÌ Áõ¸íµÇÁö ¾Ê¾Ò´Ù.

No evidence of risk in humans. Either animal finding show risk, but human findings do not; or if no adequate human studies have been done, animal findings are negative.
»ç¶÷¿¡¼­ À§ÇèÇÏ´Ù´Â Áõ°Å°¡ ¾ø´Ù.
µ¿¹°¿¬±¸¿¡¼­´Â À§Ç輺À» º¸¿´À¸³ª »ç¶÷¿¡¼­´Â º¸ÀÌÁö ¾Ê¾Ò´Ù; ¶Ç´Â »ç¶÷¿¡ ´ëÇÑ ÀûÀýÇÑ ¿¬±¸°¡ ½Ç½ÃµÇÁö ¾Ê¾Ò´Ù¸é, µ¿¹°¿¬±¸¿¡¼­ ÅÂÀÚ¿¡ ´ëÇÑ À§Ç輺À» º¸ÀÌÁö ¾Ê¾Ò´Ù.

Risk cannot be ruled out. Human studies are lacking, and animal studies are either positive for fetal risk or lacking. However, potential benefits may justify the potential risks.
À§Ç輺À» ¹èÁ¦ÇÒ ¼ö ¾ø´Ù.
»ç¶÷¿¡ ´ëÇÑ ¿¬±¸´Â ºÎÁ·Çϰí, µ¿¹°¿¬±¸¿¡¼­´Â ÅÂÀÚ¿¡ ´ëÇÑ À§Ç輺À» º¸À̰ųª µ¿¹°¿¡ ´ëÇÑ ¿¬±¸°¡ ºÎÁ·ÇÏ´Ù. ÀáÀçÀû À§Ç輺¿¡µµ ºÒ±¸Çϰí, ¾à¹° »ç¿ë½ÃÀÇ À¯ÀͼºÀÌ ¾à¹°»ç¿ëÀ» Á¤´çÈ­ÇÒ ¼öµµ ÀÖ´Ù.
Positive evidence of risk. Investigational or post-marketing data show risk to the fetus. Nevertheless, potential benefits may outweigh the potential risks. If needed in a life-threatening situation or a serious disease, the drug may be acceptable if safer drugs cannot be used or are ineffective.
À§ÇèÇÏ´Ù´Â Áõ°Å°¡ ÀÖ´Ù.
ÀÓ»óÀڷᳪ ½ÃÆÇÈÄ ÀÚ·á¿¡¼­ žƿ¡ ´ëÇÑ À§Ç輺À» º¸ÀδÙ. ±×·³¿¡µµ ºÒ±¸Çϰí, ¾à¹° »ç¿ëÀÇ À¯ÀͼºÀÌ ÀáÀçÀû À§Ç輺À» »óȸÇÒ ¼ö ÀÖ´Ù. »ý¸íÀ» À§ÇùÇÏ´Â »óȲÀ̳ª ÁßÁõ Áúȯ¿¡ »ç¿ëÀÌ ÇÊ¿äÇÑ °æ¿ì, º¸´Ù ¾ÈÀüÇÑ ¾à¹°À» »ç¿ëÇÒ ¼ö ¾ø°Å³ª º¸´Ù ¾ÈÀüÇÑ ¾à¹°ÀÌ È¿°ú°¡ ¾ø´Ù¸é »ç¿ëÇÒ ¼öµµ ÀÖ´Ù.

Contraindicated in pregnancy. Studies in animals or human, or investigational or post-marketing reports have shown fetal risk which clearly outweighs any possible benefit to the patient.
ÀÓ½ÅÁß Åõ¿©±Ý±â.
µ¿¹°À̳ª »ç¶÷¿¡ ´ëÇÑ ¿¬±¸ ¶Ç´Â ÀÓ»ó½ÃÇèÀ̳ª ½ÃÆÇÈĺ¸°í¿¡¼­ žƿ¡ ´ëÇÑ À§Ç輺ÀÌ È¯ÀÚ¿¡ ´ëÇÑ ¾î¶² À¯Àͼºº¸´Ù ¸í¹éÈ÷ »óȸÇÏ´Â °ÍÀ» º¸¿´´Ù.

* Regardless of the designated Pregnancy Category or presumed safety, no drug should be administered during pregnancy unless it is clearly needed and potential benefits outweigh potential hazards to the fetus.
ÁöÁ¤µÈ Pregnancy Category ³ª ¾ÈÀüÇÏ´Ù°í ¿©°ÜÁö´Â °Í¿¡ °ü°è¾øÀÌ, ¸í¹éÈ÷ ÇÊ¿äÇϰí & »ç¿ë½ÃÀÇ À¯ÀͼºÀÌ Å¾ƿ¡ ´ëÇÑ ÀáÀçÀû À§Ç輺À» »óȸÇÏ´Â °æ¿ì°¡ ¾Æ´Ï¶ó¸é ¾î¶² ¾à¹°µµ ÀÓ½ÅÁß¿¡ Åõ¿©µÇ¾î¼­´Â ¾ÈµÈ´Ù.

 
     
 
Digoxin, Ferrous Sulfate, Folic Acid, Levothyroxine Sodium, Liothyronine Sodium, Liotrix, Magnesium Sulfate, Pyridoxine HCl

Acarbose, Acetaminophene, Amoxicillin & Potassium Clavulanate, Cefaclor, Cimetidine, Diphenhydramine HCl, Erythromycin, Fluoxetine HCl, Insulin, Loperamide HCl, Metoclopramide, Metronidazole, Orlistat

Acyclovir, Alendronate Sodium, Aspirin, Atenolol, Budesonide, Celecoxib, Ciprofloxacin HCl, Dexamethasone, Itraconazole, Nifedipine, Ofloxacin, Omeprazole, Prednisolone, Salbutamol(Albuterol), Sumatriptan Succinate
Diazepam, Doxycycline, Enalapril Maleate, Neomycin Sulfate, Phenobarbital, Propylthiouracil, Tetracycline HCl

Atorvastatin Calcium, Ergotamine Tartrate, Estradiol, Estrogens conjugated, Finasteride, Levonorgestrel, Raloxifene HCl, Testosterone, Warfarin Sodium
 
       
 
 
 
 
'-'Çü     '+'Çü
¾øÀ½     ±âŸ
¹ÂÄÚÁ¹Á¤
º¹Çշθ߽ÅÁ¤
º¹ÇÕ¾Æ·çÆæÆ®Á¤
ºÎ·Î¸¶Á¤
·ÎÀÌÄܽ÷´
¼¿Æ®¶óÁ¤50mg
¼Ò¾Æ¿ëÄÚÆÇ½Ã·´
ÀÚÀÌÇÁ·º»çÁ¤5mg
µ¿½Å»ý¸®½Ä¿°ÁÖ»ç¾×5ml
·º»çÇÁ·ÎÁ¤10mg